Hims & Hers Health (HIMS) Company Overview

Hims & Hers is facing criticism for a weight loss advertisement that is set to air during the Super Bowl on Sunday. Two U.S. senators have raised concerns about the ad, stating that it could mislead patients by not including important safety and side effect information.

On Friday, stock markets reacted strongly after a survey from the University of Michigan revealed that consumers expect inflation to increase in 2025. This could lead to lower consumer spending and might prevent the Federal Reserve from reducing interest rates any further.

Three companies that are in a stronger position to handle the challenges posed by Trump's tariffs are ResMed, Hims & Hers Health, and Medtronic.

Users of Zacks.com have been paying a lot of attention to Hims & Hers Health (HIMS) lately. Therefore, it's important to understand the key information that could influence the future of the stock.

HIMS is improving its range of health and wellness products and services. However, larger economic issues may negatively impact its performance.

Hims & Hers Health, Inc. (HIMS) finished the last trading session at $31.86, which represents a 1.01% increase from the previous day's closing price.

I expect that the FDA will soon announce that the shortage of semaglutide is over, which might slow down Hims' revenue growth because of compounding limits. After the FDA's announcement, I predict a significant increase in revenue due to the 60-day and 90-day deadlines for pharmacies and outsourcing facilities to meet the new rules. I think HIMS could use FDA compounding exemptions to expand its GLP-1 products, which could create uncertainty for those who are betting against the stock.

Founded in 2017, Hims & Hers Health (HIMS -1.17%) is a new company tackling long-standing healthcare issues by providing prescription drugs, over-the-counter items, and personal care products directly to consumers. After becoming a public company through a SPAC merger in 2021, both the telehealth firm and its stock have undergone significant changes.

Hims & Hers Health, Inc. (HIMS) finished the latest trading session at $29.72, which represents a decrease of 0.3% compared to the previous day's closing price.